Health Services Evaluation and Clinical Epidemiology

Director

Nieves Lopez Fresneña

Group type

EMERGING

Research lines

Axis 1: Precision medicine, innovation, regenerative medicine and big data

L1: Evaluation of health services and public health programs.

L2: Patient safety and management of risks resulting from clinical practice.

L3: Prevention of health care-related infections.

Axis 2: Boosting research in primary care and nursing

L1: Evaluation of health services and public health services.